Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Frontiers in immunology(2022)
摘要
We propose a blood-based signature of cytokines and growth factors that can be employed in identifying cancer patients at persistent high risk of COVID-19 despite vaccination with BNT162b2. Our data also suggest that such a signature may reflect the inherent immunological constitution of some cancer patients who are refractive to immunotherapy.
更多查看译文
关键词
BNT162b2,COVID-19 vaccine,SARS-CoV-2,chemokines,cytokines,growth factors,haematological malignancies,solid cancers
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要